FLoRA Replication Atlas › Browse

The price of innovation: new estimates of drug development costs

Joseph A DiMasi, Ronald W Hansen, Henry G Grabowski

Journal of Health Economics, 2003. DOI 10.1016/s0167-6296(02)00126-1

Has this study been replicated?

The atlas records 1 replication of this study. Recorded outcomes: 1 mixed. The earliest on record is from 2009.

Replications

• Spending on new drug development1, Adams & Brantner (2009). Health Economics. Outcome recorded: mixed. The paper's estimated expenditure on new drug development is somewhat greater than suggested by the survey results presented in DiMasi et al. Outcome read from the abstract. View paper

Cite this record

DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003). The price of innovation: new estimates of drug development costs. Journal of Health Economics, 22(2), 151–185. https://doi.org/10.1016/s0167-6296(02)00126-1

Other studies in the atlas

• Exploring the relation between family involvement and firms' financial performance: A…
• Can Short Psychological Interventions Affect Educational Performance? Revisiting the…
• What you hear shapes how you think: Sound patterns change level of construal
• Replication and cross-validation of type 2 diabetes subtypes based on clinical…
• Student and Teacher Outcomes of the Class-Wide Function-Related Intervention Team…
• Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

Failed replications · Successful replications · All browse pages